Review ArticlePD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee
Keywords
Cited by (0)
Disclosure: Dr. Lantuejoul received advisory board honoraria from AbbVie, AstraZeneca, Bayer, Bristol-Myers Squibb, Merck Sharp and Dohme, Takeda, Roche/Genentech; Dr. Tsao reports grants and personal fees from Merck, AstraZeneca, Pfizer, and Bayer and personal fees from Bristol-Myers Squibb, Hoffmann La Roche, Takeda, Medscape prIME Oncology, outside the submitted work; Dr. Girard reports grants, personal fees, and other from BMS, MSD, Roche, AstraZeneca during the conduct of the study; Dr. Lopez-Rios reports personal fees and nonfinancial support from AbbVie, Bayer, Roche, AstraZeneca, BMS, MSD, Pfizer, Thermo Fisher, and Lilly, outside the submitted work; Dr. Motoi reports grants and personal fees from Ono, Roche Diagnostics and personal fees from Bristol-Myers Squibb, AstraZeneca, Chugai Pharmaceutical, MSD, Agilent, Novartis, Taiho, grants and personal fees from, outside the submitted work; Dr. Kerr reports personal fees from AstraZeneca, Merck Serono, MSD, Ventana, BMS, Null, outside the submitted work; Dr. Yatabe reports personal fees from MDS, Chugai Pharmaceutical, AstraZeneca, Novartis, Pfizer, Roche/Ventana, Agilent/Dako, Thermo Fisher Science, outside the submitted work; Dr. Longshore reports grants from Agilent Technologies, grants and personal fees from Roche Diagnostics, AstraZeneca, Biodesix and personal fees from Bristol-Myers Squibb, Genentech, Merck, Pfizer, AbbVie, Bayer, Loxo Oncology, Spectrum Pharmaceuticals, outside the submitted work, Dr. Papotti reports personal fees from AstraZeneca, Roche, Pfizer, MSD, AbbVie, Novartis, outside the submitted work; Dr. Sholl reports personal fees from AstraZeneca, grants from Roche/ Genentech, outside the submitted work; Dr. Thunnissen reports personal fees from Histogenex, during the conduct of the study; Dr. Borczuk reports personal fees from Bristol-Myers Squibb, outside the submitted work; Dr. Bubendorf reports grants and personal fees from MSD, Roche and personal fees from BMS, AstraZeneca, outside the submitted work; Dr. Beasley reports other from Merck, BMS, Boehringer Ingelheim, Blueprint study, outside the submitted work; Dr. Botling reports grants from Bristol-Myers Squibb, personal fees from Bristol-Myers Squibb, AstraZeneca, MSD, Roche, Pfizer, Boehringer Ingelheim, Novartis, outside the submitted work; Dr. Dacic reports personal fees from Bayer, Takeda, AstraZeneca, outside the submitted work; Dr. Hwang reports personal fees from Pfizer, Roche, Bayer and grants and personal fees from Merck, AstraZeneca, Novartis, Takeda, outside the submitted work; Dr. Nicholson reports personal fees from Merck, Boehringer Ingelheim, and grants and personal fees from Pfizer, Novartis, AstraZeneca, Bristol-Myers Squib, Roche, AstraZeneca, AbbVie, Oncologica, outside the submitted work; Dr. Wistuba reports grants and personal fees from Genentech/ Roche, Asuragen, GlaxoSmithKline, grants and personal fees from AstraZeneca/ Medimmune, Bristol-Myers Squibb, Pfizer, HTG Molecular, Merck, Guardant Health, MSD, grants from DepArray, grants from Bayer, Adaptive, Adaptimmune, EMD Serono, Amgen, Takeda, Johnson & Johnson, Karus, Iovance, Novartis, 4D, Akoya, outside the submitted work; Dr. Mino-Kenudson reports personal fees from H3 Biomedicine, Merrimack Pharmaceuticals, grants from Novartis, outside the submitted work. The remaining authors declare no conflict of interest.